Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;35(2):243-9.
doi: 10.5142/jgr.2011.35.2.243.

Protective Effect of Korean Red Ginseng against Aflatoxin B1-Induced Hepatotoxicity in Rat

Affiliations

Protective Effect of Korean Red Ginseng against Aflatoxin B1-Induced Hepatotoxicity in Rat

Yong-Seong Kim et al. J Ginseng Res. 2011 Jun.

Abstract

Korean red ginseng (KRG), the steamed root of Panax ginseng Meyer, has a variety of biological properties, including anti-inflammatory, antioxidant and anticancer effects. Aflatoxin B1 (AFB1) produced by the Aspergillus spp. causes acute hepatotoxicity by lipid peroxidation and oxidative DNA damage, and induces liver carcinoma in humans and laboratory animals. This study was performed to examine the protective effects of KRG against hepatotoxicity induced by AFB1 using liver-specific serum marker analysis, histopathology, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. In addition, to elucidate the possible mechanism of hepatoprotective effects, superoxide dismutase, catalase, glutathione peroxidase, and malondialdehyde were analyzed. Rats were treated with 250 mg/kg of KRG (KRG group) or saline (AFB1 group) for 4 weeks and then received 150 μg/kg of AFB1 intraperitoneally for 3 days. Rats were sacrificed at 12 h, 24 h, 48 h, 72 h, or 1 wk after AFB1 treatment. In the KRG pre-treatment group, serum alanine aminotransferase, aspartate aminotransferase, and malondialdehyde levels were low, but superoxide dismutase, catalase, and glutathione peroxidase activities were high as compared to the AFB1 alone group. Histopathologically, AFB1 treatment induced necrosis and apoptosis in hepatocytes, and led to inflammatory cells infiltration in the liver. KRG pre-treatment ameliorated these changes. These results indicate that KRG may have protective effects against hepatotoxicity induced by AFB1 that involve the antioxidant properties of KRG.

Keywords: Aflatoxin B1; Antioxidant enzymes; Korean red ginseng; Panax ginseng.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Liver specific serum biomarker analysis in rats treated with Aflatoxin B1 (AFB1) with or without Korean red ginseng (KRG). Serum alanine aminotransferase (A) and aspartate aminotransferase (B) were relatively low in group pretreated with KRG compared to the group treated only with AFB1.
Fig. 2.
Fig. 2.. Representative photomicrograph of liver lesions in rats treated with Aflatoxin B1 (AFB1) with or without Korean red ginseng (KRG) pretreatment. H&E stain. (A,B) Centrilobular (CV) and periportal (PT) zone of the control group. Bar=50 μm. (C) Hepatic lesion found in the AFB1-treated group after 12 h; severe necrosis of hepatocytes and loss of hepatic cords were observed around the portal region. Bar=100 μm. (D) Higher magnification of (C). Severe hepatocyte necrosis was noted around the portal triad. Bar=50 μm. (E) Hepatic lesions of the KRG pretreated group after 12 h; mild necrosis in hepatocytes and loss of hepatic cords were observed around the portal region. Bar=100 μm. (F) Higher magnification of (E). Mild hepatocyte necrosis was noted around the portal triad. Bar=50 μm.
Fig. 3.
Fig. 3.. Apoptosis in liver of rats treated with Aflatoxin B1 (AFB1) with or without Korean red ginseng (KRG) pretreatment. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) stain. Bar=50 μm. (A) Control group; few TUNEL-labeled apoptotic cells (arrow) were noted. (B) AFB1 group; at 12 h many apoptotic cells were observed. (C) KRG pretreated group; at 12 h the number of apoptotic cells decreased compared to the AFB1 group. (D) AFB1 group; at 48 h the number of apoptotic cells decreased. CV, central vein; PT, portal triad.
Fig. 4.
Fig. 4.. Level of hepatic antioxidant enzymes in rats treated with Aflatoxin B1 (AFB1) with or without Korean red ginseng (KRG) pretreatment. Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) enzyme activity was increased after 12 h in the KRG and AFB1 groups compared to the control group. These enzyme activities were relatively higher in the KRG group compared to the AFB1 group.
Fig. 5.
Fig. 5.. The levels of malondialdehyde (MDA), a natural byproduct of lipid peroxidation, in the plasma and liver of rats treated with Aflatoxin B1 (AFB1) with or without Korean red ginseng (KRG) pretreatment. Plasma MDA levels were higher in the AFB1 group compared to the control and KRG group at each time point except at 72 h. In addition, MDA levels in the liver were higher in the AFB1 group than the control and KRG groups at 12 and 24 h. *Significantly different from the control and KRG group.

References

    1. Chao TC, Maxwell SM, Wong SY. An outbreak of aflatoxicosis and boric acid poisoning in Malaysia: a clinicopathological study. J Pathol. 1991;164:225–233. doi: 10.1002/path.1711640307. - DOI - PubMed
    1. Ueng YF, Shimada T, Yamazaki H, Guengerich FP. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxicol. 1995;8:218–225. doi: 10.1021/tx00044a006. - DOI - PubMed
    1. Metcalfe SA, Colley PJ, Neal GE. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro. Chem Biol Interact. 1981;35:145–157. doi: 10.1016/0009-2797(81)90139-3. - DOI - PubMed
    1. Judah DJ, Hayes JD, Yang JC, Lian LY, Roberts GC, Farmer PB, Lamb JH, Neal GE. A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant. Biochem J. 1993;292(Pt 1):13–18. - PMC - PubMed
    1. Gorelick NJ. Risk assessment for aflatoxin. I. Metabolism of aflatoxin B1 by different species. Risk Anal. 1990;10:539–559. doi: 10.1111/j.1539-6924.1990.tb00538.x. - DOI - PubMed

LinkOut - more resources